AI for Healthcare in China
Practical Pathways for Growth
When entering China’s healthcare market, digital solution providers quickly realize that regulatory, data, and market access barriers are just as critical as performance. AI-assisted medical imaging and remote diagnostics offer significant opportunities if pursued with the right localization, compliance, and partnership strategies, whereas areas such as cloud-based patient data processing remain heavility restricted.
On September 25, we’re diving into the real-world pathways (and roadblocks) for scaling AI solutions in China’s healthcare sector — from regulatory hurdles to partnership strategies.
Featuring Chenchao Liu, MD of SILREAL, in conversation with Erik Walenza, CEO of Asia Growth Partners.
Sep 25 | 15:00–16:00 CN/SG | 9:00–10:00 CET 📍 MS Teams
“Invite-Only” for IT + Business + Operations managers interested in scaling AI
